UPS invests $48 million in climate-controlled facilities to meet GLP-1 drug demand

UPS is allocating $48 million towards new temperature-controlled logistics centers to support the rising consumption of weight-loss drugs like Ozempic. This expansion addresses the specific storage needs of GLP-1 medications, which require refrigeration. Watch for how this infrastructure build-up impacts UPS's logistics capacity and earnings.